A novel vector platform for vitamin H-inducible transgene expression in mammalian cells

Journal of Biotechnology

Volumn 131, Issue 2, 2007, Pages 150-158

  Weber, Wilfried ^a   Bacchus, William ^a   Gruber, Franziska ^a   Hamberger, Mattia ^a   Fussenegger, Martin ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Biopharmaceutical manufacturing; Biotin; Expression control; Gene regulation; Macrolide; Mammalian cells; Streptogramin

Indexed keywords

BIOPHARMACEUTICAL MANUFACTURING; BIOTINS; EXPRESSION CONTROL; GENE REGULATION; MACROLIDES; MAMMALIAN CELLS; STREPTOGRAMIN;

ANTIBIOTICS; CYTOLOGY; DIMERIZATION; ENZYME KINETICS; ESCHERICHIA COLI;

GENE EXPRESSION;

ANTIBIOTIC AGENT; AVIDIN; BIOTIN; BIOTIN LIGASE; ETOPOSIDE; HETERODIMER; LIGASE; MACROLIDE; STREPTAVIDIN; STREPTOGRAMIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ARTICLE; ESCHERICHIA COLI; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MAMMAL CELL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOTIN; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HELA CELLS; HUMANS; LENTIVIRUS; MICE; MODELS, BIOLOGICAL; NIH 3T3 CELLS; PLASMIDS; TRANSFECTION; TRANSGENES; VIRION;

ANIMALIA; ESCHERICHIA COLI; MAMMALIA;

EID: 34547550144     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2007.06.008     Document Type: Article

References (42)

1. Aarestrup F.M. Veterinary drug usage and antimicrobial resistance in bacteria of animal origin. Basic Clin. Pharmacol. Toxicol. 96 (2005) 271-281
2. Aubel D., Morris R., Lennon B., Rimann M., Kaufmann H., Folcher M., Bailey J.E., Thompson C.J., and Fussenegger M. Design of a novel mammalian screening system for the detection of bioavailable, non-cytotoxic streptogramin antibiotics. J. Antibiot. (Tokyo) 54 (2001) 44-55
3. Beckett D., Kovaleva E., and Schatz P.J. A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci. 8 (1999) 921-929
4. Bohl D., and Heard J.M. Modulation of erythropoietin delivery from engineered muscles in mice. Hum. Gene Ther. 8 (1997) 195-204
5. Folcher M., Morris R.P., Dale G., Salah-Bey-Hocini K., Viollier P.H., and Thompson C.J. A transcriptional regulator of a pristinamycin resistance gene in Streptomyces coelicolor. J. Biol. Chem. 276 (2001) 1479-1485
6. Fussenegger M., Mazur X., and Bailey J.E. pTRIDENT, a novel vector family for tricistronic gene expression in mammalian cells. Biotechnol. Bioeng. 57 (1998) 1-10
7. Fussenegger M., Schlatter S., Datwyler D., Mazur X., and Bailey J.E. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat. Biotechnol. 16 (1998) 468-472
8. Fussenegger M., Morris R.P., Fux C., Rimann M., von Stockar B., Thompson C.J., and Bailey J.E. Streptogramin-based gene regulation systems for mammalian cells. Nat. Biotechnol. 18 (2000) 1203-1208
9. Fussenegger M. The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol. Prog. 17 (2001) 1-51
10. Fux C., Langer D., Kelm J.M., Weber W., and Fussenegger M. New-generation multicistronic expression platform: pTRIDENT vectors containing size-optimized IRES elements enable homing endonuclease-based cistron swapping into lentiviral expression vectors. Biotechnol. Bioeng. 86 (2004) 174-187
11. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89 (1992) 5547-5551
12. Hillen W., and Berens C. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol. 48 (1994) 345-369
13. Kapunisk-Uner J.E., Sande M.A., and Chambers H.F.S. Tetracycline, Chloramphenicol, Erythromycin and Miscellaneous Antibacterial Agents (1996), McGraw-Hill, New York
14. Kohanski R.A., and Lane M.D. Monovalent avidin affinity columns. Methods Enzymol. 184 (1990) 194-200
15. Kramer B.P., Weber W., and Fussenegger M. Artificial regulatory networks and cascades for discrete multilevel transgene control in mammalian cells. Biotechnol. Bioeng. 83 (2003) 810-820
16. Kramer B.P., Fischer C., and Fussenegger M. BioLogic gates enable logical transcription control in mammalian cells. Biotechnol. Bioeng. 87 (2004) 478-484
17. Kramer B.P., Viretta A.U., Daoud-El-Baba M., Aubel D., Weber W., and Fussenegger M. An engineered epigenetic transgene switch in mammalian cells. Nat. Biotechnol. 22 (2004) 867-870
18. Kramer B.P., and Fussenegger M. Hysteresis in a synthetic mammalian gene network. Proc. Natl. Acad. Sci. USA 102 (2005) 9517-9522
19. Kramer B.P., Fischer M., and Fussenegger M. Semi-synthetic mammalian gene regulatory networks. Metab. Eng. 7 (2005) 241-250
20. Malleret G., Haditsch U., Genoux D., Jones M.W., Bliss T.V., Vanhoose A.M., Weitlauf C., Kandel E.R., Winder D.G., and Mansuy I.M. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 104 (2001) 675-686
21. Mitta B., Rimann M., Ehrengruber M.U., Ehrbar M., Djonov V., Kelm J., and Fussenegger M. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res. 30 (2002) e113
22. Mitta B., Weber C.C., Rimann M., and Fussenegger M. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression. Nucleic Acids Res. 32 (2004) e106
23. Mitta B., Rimann M., and Fussenegger M. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles. Metab. Eng. 7 (2005) 426-436
24. Mitta B., Weber C.C., and Fussenegger M. In vivo transduction of HIV-1-derived lentiviral particles engineered for macrolide-adjustable transgene expression. J. Gene Med. 7 (2005) 1400-1408
25. Mochizuki H., Schwartz J.P., Tanaka K., Brady R.O., and Reiser J. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72 (1998) 8873-8883
26. Moser S., Schlatter S., Fux C., Rimann M., Bailey J.E., and Fussenegger M. An update of pTRIDENT multicistronic expression vectors: pTRIDENTs containing novel streptogramin-responsive promoters. Biotechnol. Prog. 16 (2000) 724-735
27. Moser S., Rimann M., Fux C., Schlatter S., Bailey J.E., and Fussenegger M. Dual-regulated expression technology: a new era in the adjustment of heterologous gene expression in mammalian cells. J. Gene Med. 3 (2001) 529-549
28. Noguchi N., Takada K., Katayama J., Emura A., and Sasatsu M. Regulation of transcription of the mph(A) gene for macrolide 2′-phosphotransferase I in Escherichia coli: characterization of the regulatory gene mphR(A). J. Bacteriol. 182 (2000) 5052-5058
29. Regulier E., Pereira de Almeida L., Sommer B., Aebischer P., and Deglon N. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum. Gene Ther. 13 (2002) 1981-1990
30. Regulier E., Trottier Y., Perrin V., Aebischer P., and Deglon N. Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum. Hum. Mol. Genet. 12 (2003) 2827-2836
31. Reiser J., Harmison G., Kluepfel-Stahl S., Brady R.O., Karlsson S., and Schubert M. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93 (1996) 15266-15271
32. Rendahl K.G., Quiroz D., Ladner M., Coyne M., Seltzer J., Manning W.C., and Escobedo J.A. Tightly regulated long-term erythropoietin expression in vivo using tet-inducible recombinant adeno-associated viral vectors. Hum. Gene Ther. 13 (2002) 335-342
33. Schlatter S., Rimann M., Kelm J., and Fussenegger M. SAMY, a novel mammalian reporter gene derived from Bacillus stearothermophilus alpha-amylase. Gene 282 (2002) 19-31
34. Triezenberg S.J., Kingsbury R.C., and McKnight S.L. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev. 2 (1988) 718-729
35. Umana P., Jean-Mairet J., and Bailey J.E. Tetracycline-regulated overexpression of glycosyltransferases in Chinese hamster ovary cells. Biotechnol. Bioeng. 65 (1999) 542-549
36. Weber W., Fux C., Daoud-el Baba M., Keller B., Weber C.C., Kramer B.P., Heinzen C., Aubel D., Bailey J.E., and Fussenegger M. Macrolide-based transgene control in mammalian cells and mice. Nat. Biotechnol. 20 (2002) 901-907
37. Weber W., Marty R.R., Keller B., Rimann M., Kramer B.P., and Fussenegger M. Versatile macrolide-responsive mammalian expression vectors for multiregulated multigene metabolic engineering. Biotechnol. Bioeng. 80 (2002) 691-705
38. Weber W., Kramer B.P., Fux C., Keller B., and Fussenegger M. Novel promoter/transactivator configurations for macrolide- and streptogramin-responsive transgene expression in mammalian cells. J. Gene Med. 4 (2002) 676-686
39. Weber C.C., Link N., Fux C., Zisch A.H., Weber W., and Fussenegger M. Broad-spectrum protein biosensors for class-specific detection of antibiotics. Biotechnol. Bioeng. 89 (2005) 9-17
40. Weber W., Malphettes L., Rinderknecht M., Schoenmakers R.G., Spielmann M., Keller B., van de Wetering P., Weber C.C., and Fussenegger M. Quorum-sensing-based toolbox for regulatable transgene and siRNA expression in mammalian cells. Biotechnol. Prog. 21 (2005) 178-185
41. Weber W., and Fussenegger M. Pharmacologic transgene control systems for gene therapy. J. Gene Med. 8 (2006) 535-556
42. Weber W., Stelling J., Rimann M., Keller B., Daoud-El Baba M., Weber C.C., Aubel D., and Fussenegger M. A synthetic time-delay circuit in mammalian cells and mice. Proc Natl Acad Sci USA. 104 (2007) 2643-2648